Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.78
+0.53 (5.73%)
At close: Aug 21, 2026, 4:00 PM EDT
9.70
-0.08 (-0.82%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Burning Rock Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-59.32-55.35-346.63-653.69-971.23-796.7
Depreciation & Amortization
21.6221.6251.39131.45120.7544.6
Other Amortization
0.140.140.811.953.353.16
Loss (Gain) From Sale of Assets
-0.2-0.22.21.011.420.18
Asset Writedown & Restructuring Costs
--35.13---
Loss (Gain) From Sale of Investments
--0.25---
Loss (Gain) on Equity Investments
--0.090.360.290.48
Stock-Based Compensation
13.8813.88155.62260.72326.78282.43
Provision & Write-off of Bad Debts
17.1817.1810.5418.524.9212.12
Other Operating Activities
31.8733.6834.8736.0748.0738.23
Change in Accounts Receivable
-33.23-33.23-26.8-16.4-42.16-49.77
Change in Inventory
2.52.52.5157.28-21.65-67
Change in Accounts Payable
7.187.1818.89-31.1216.63-5.1
Change in Unearned Revenue
-10.31-10.31-13.5-16.675.4368.21
Change in Other Net Operating Assets
-25.53-25.53-17.63-45.2430.6-8.73
Operating Cash Flow
-34.22-28.44-92.26-255.78-456.81-477.89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.25-5.25-5.42-8.1-70.29-210.92
Sale of Property, Plant & Equipment
0.860.861.570.082.410.57
Sale (Purchase) of Intangibles
---0.56-1.28-0.19-2.53
Investment in Securities
----65.6294.58
Investing Cash Flow
-3.22-4.39-4.41-9.3-7.4681.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2----
Total Debt Issued
22----
Short-Term Debt Repaid
-----2.37-5
Long-Term Debt Repaid
--0.1----39.81
Total Debt Repaid
-0.1-0.1---2.37-44.81
Net Debt Issued (Repaid)
1.91.9---2.37-44.81
Repurchase of Common Stock
---0.07-6.98-71.83-4.27
Other Financing Activities
----41.86-12.04-3.82
Financing Cash Flow
1.91.9-0.07-48.83-86.24-52.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-13.13-10.143.693.8636.67-37.01
Net Cash Flow
-48.68-41.07-93.05-310.05-513.84-486.09

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-39.47-33.69-97.68-263.89-527.1-688.81
Free Cash Flow Growth
------
Free Cash Flow Margin
-7.67%-6.24%-18.94%-49.10%-93.58%-135.63%
Free Cash Flow Per Share
-3.73-3.17-9.49-25.77-50.73-66.10
Levered Free Cash Flow
-18.97-22.79-7.71-57.45-220.17-305.26
Unlevered Free Cash Flow
-18.94-22.77-7.71-57.45-220.17-304.3

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.030.03--0.881.52
Cash Income Tax Paid
----0.11.11
Change in Working Capital
-59.39-59.39-36.53-52.16-11.16-62.4
SEC Filings: 10-K · 10-Q